Indications and uses
Temporarily relieves mild to moderate aches and pains of muscles and joints associated with: • muscle soreness • strains • sprains • arthritis • simple backache • muscle stiffness • bruises
EZ-Relief
- Manufacturer
- Primary Pharmaceuticals, Inc.
- Effective date
- 2023-07-09
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:29:00
Label at a glance#
ProductEZ-Relief
Active ingredientLIDOCAINE, CAMPHOR (NATURAL), METHYL SALICYLATE
Label structure15 sections
Dosage and administration
Ad ults, or children over the age of 12: • Apply patch to affected area 1 to 2 times daily or as directed.
Storage and handling
• some individuals may not experience pain relief until several minutes or hours after applying the patch • store in a cool, dry place • protect product from excessive moisture or sunlight • store at 67-77°F (19-25°C)
Contacts and useful links#
Label contents#
Full prescribing information#
DRUG FACTS
DRUG FACTS
Active Ingredient
Camphor 2%
Purpose
Topical Analgesic
Active Ingredient
Lidocaine 2.5%
Purpose
Topical Anesthetic
Active Ingredient
Methyl Salicylate 4%
(NSAID: nonsteroidal anti-inflammatory drug)
Purpose
Topical Analgesic
Uses
Temporarily relieves mild to moderate aches and pains of muscles and joints associated with:
• muscle soreness
• strains
• sprains
• arthritis
• simple backache
• muscle stiffness
• bruises
Warnings
For external use only
Stomach bleeding warning
This product contains an NSAID, which may cause stomach bleeding. The chance is small, but higher if you
• are age 60 or older
• have had stomach ulcers or bleeding problems
• take other drugs containing an NSAID (Aspirin, Ibuprofen, Naproxen, or others)
• take a blood thinning (anticoagulant) or steroid drug
• have three or more alcoholic drinks every day while using this product
• take more or for a longer time than directed
Do not use
• on the face or rashes; on wounds or damaged skin
• in the eyes, mouth, or other mucous membranes
• on genitals
• with a heating pad
• if allergic to any NSAIDS
• right before or after heart surgery
• any patch from a pouch that has been opened for 7 or more days
Ask a doctor before use if
• you are allergic to topical products
• the stomach bleeding warning applies to you
• you are taking a diuretic
• you have high blood pressure, heart disease, or kidney disease
• you are pregnant
When using this product
• wash hands after applying or removing patch
• avoid contact with eyes. If eye contact occurs, rinse thoroughly with water
• the risk of heart attack or stroke may increase if you use more than directed or for longer than directed.
Stop use and consult your physician if
• stomach pain or upset gets worse or lasts
• rash, irritation, or itching develops
• you feel faint, vomit blood, or have bloody or black stools (these are signs of stomach bleeding)
• condition worsens
If pregnant or breast feeding,
ask a doctor before use while breast feeding and during the first 6 months of pregnancy. Do not use during last 3 months of pregnancy because it may cause problems in the unborn child or complications during delivery.
Keep out of reach of children.
If put in mouth, get medical help or contact a Poison Control Center right away. Package not child resistant. Dispose of the used patches by folding sticky ends together.
Directions
Adults, or children over the age of 12:
• Apply patch to affected area 1 to 2 times daily or as directed.
Instructions for Use
• clean and dry affected area
• open pouch and remove one patch
• remove protective film from patch
• apply one patch to the affected area of pain and leave in place for 8 to 12 hours
• if pain lasts after using the first patch, a second patch may be applied for up to another 8 to 12 hours
• only use one patch at a time
• do not use more than 2 patches per day
• wash hands with soap and water after applying or removing patch
• reseal pouch containing unused patches immediately after each use
Children under 12 years of age: Do not use
Other Information
• some individuals may not experience pain relief until several minutes or hours after applying the patch
• store in a cool, dry place
• protect product from excessive moisture or sunlight
• store at 67-77°F (19-25°C)
INACTIVE INGREDIENT SECTION
Acrylic Acid, Aluminum Hydroxide, Carmellose Sodium, 2-Ethylhexyl Acrylate, Glycerin, Isopropyl Myristate, Methyl Acrylate, Nonoxynol-30, Polyacrylic Acid, Polysorbate 80, Sodium Polyacrylate, Sorbitan Sesquioleate, Starch, Talc, Tartaric Acid, Titanium Dioxide, Water
SPL UNCLASSIFIED SECTION
Original Manufacturer
Terrain Pharmaceuticals
Reno, NV 89501
TerrainRx.com
877-985-8377
Distributed by:
Primary Pharmaceuticals, Inc.
Ocean Springs MS 39564
Principal Display Panel
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72275-008-15 | EA - Each | 72275-008 | e4ef2a92-bbff-4551-a5c6-92cfeae7869a | 1 | 2021-01-08 |
Products#
Every source-derived product name is available through these pages.
- EZ-Relief
- Camphor, Lidocaine, and Methyl Salicylate
- ALUMINUM HYDROXIDE
- CARBOXYMETHYLCELLULOSE SODIUM
- 2-ETHYLHEXYL ACRYLATE
- GLYCERIN
- ISOPROPYL MYRISTATE
- METHYL ACRYLATE
- SODIUM POLYACRYLATE (8000 MW)
- NONOXYNOL-30
- POLYACRYLIC ACID (250000 MW)
- ACRYLIC ACID
- POLYSORBATE 80
- SORBITAN SESQUIOLEATE
- STARCH, CORN
- TALC
- TARTARIC ACID
- TITANIUM DIOXIDE
- WATER
- LIDOCAINE
- CAMPHOR (NATURAL)
- METHYL SALICYLATE
- SALICYLIC ACID
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72275-008 | 72275-008-15 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2f23d297-1dd2-227a-e063-6294a90acaf1 | b5a8a1bf-05c2-e0ca-e053-2995a90ae62f | 2025-02-27 | Warnings | b5a8a1bf-05c2-e0ca-e053-2995a90ae62f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.